Aiforia and Finnish pharmaceutical company Orion have agreed to collaborate on developing AI-based image analysis solutions for preclinical research and product development. Aiforia Technologies Plc, Press Release, 05 July 2023 at 12:00 a.m....

Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding...

Aiforia is happy to announce the win of this contract award, which enables us to offer our AI solutions directly for 25 NHS Trusts pathology departments in the UK. Aiforia has received a contract award to provide artificial intelligence...

Epredia: Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program WINSTON-SALEM, N.C.--(BUSINESS WIRE)--PHC Group, a global healthcare company and leader in diagnostics and life sciences, will expand its presence in...

Aiforia Technologies Plc is thrilled to announce it received CE-IVD marking for the Aiforia® Clinical Suite Viewer, a cloud-based platform enabling a holistic approach to cancer diagnostics and prognostics through the viewing of whole slide...

Aiforia Technologies Plc announces the CE-IVD marking of the Aiforia® Clinical AI Model for Prostate Cancer; Gleason Grade Groups. This latest regulatory certification brings Aiforia’s portfolio of AI-powered diagnostic tools to a total of 5...